Inicio › Cáncer de próstata › Utah › Salt Lake City
Ensayos clínicos de Cáncer de próstata en Salt Lake City, UT
15 estudios para Cáncer de próstata buscan participantes en centros de Salt Lake City y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Study of AR Suppression With Carotuximab in Metastatic, Castration-Resistant Prostate Canc
ReclutandoFase 2
- Huntsman Cancer Institute and Hospital, Salt Lake City
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
ReclutandoFase 3
- LDS Hospital, Salt Lake City
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
ReclutandoFase 1
- University of Utah - Huntsman Cancer Institute, Salt Lake City
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
ReclutandoFase 3
- Huntsman Cancer Institute, Salt Lake City
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
ReclutandoFase 3
- University of Utah Sugarhouse Health Center, Salt Lake City
- Huntsman Cancer Institute/University of Utah, Salt Lake City
- LDS Hospital, Salt Lake City
- y 1 más
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
ReclutandoFase 3
- Research Site, Salt Lake City
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
ReclutandoFase 3
- Huntsman Cancer Institute/University of Utah, Salt Lake City
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
ReclutandoFase 1
- Huntsman Cancer Institute, University of Utah, Salt Lake City
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer
ReclutandoFase 2
- Huntsman Cancer Institute/University of Utah, Salt Lake City
Creatine Supplementation and Resistance Training to Preserve Muscle Mass and Attenuate Cancer Progression
ReclutandoFase 3
- Huntsman Cancer Institute, Salt Lake City
Multimodal Telerehabilitation of Rural Patients With Advanced Prostate Cancer
Reclutando
- Huntsman Cancer Institute at University of Utah, Salt Lake City
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
ReclutandoFase 1/2
- START Center for Cancer Care - Mountain Region, Salt Lake City
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ReclutandoEstudio observacional
- Massive Bio SYNERGY-AI site, Salt Lake City
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
ReclutandoFase 3
- University of Utah Sugarhouse Health Center, Salt Lake City
- Huntsman Cancer Institute/University of Utah, Salt Lake City
- George E Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
Impact of Multimodal Telerehabilitation in Rural Patients With Metastatic Prostate Cancer
Reclutando
- University of Utah Huntsman Cancer Institute, Salt Lake City
Más información sobre Cáncer de próstata en MedlinePlus
Ensayos de Cáncer de próstata en otras ciudades
- New York City, NY102 estudios
- Houston, TX75 estudios
- Los Angeles, CA60 estudios
- Boston, MA59 estudios
- St. Louis, MO46 estudios
- San Francisco, CA45 estudios
- Chicago, IL45 estudios
- Philadelphia, PA44 estudios
- Baltimore, MD43 estudios
- Nashville, TN43 estudios
- Seattle, WA42 estudios
- Washington, DC38 estudios
Otros estudios en Salt Lake City
- Cáncer de pulmón de células no pequeñas31 estudios
- Cáncer de seno28 estudios
- Cáncer (todos los tipos)27 estudios
- Cáncer del colon y del recto22 estudios
- Melanoma21 estudios
- Mieloma múltiple21 estudios
- Cáncer de pulmón21 estudios
- Cáncer metastásico20 estudios
- Cáncer de ovario19 estudios
- Fallo cardíaco17 estudios
- Leucemia mielógena aguda17 estudios
- Obesidad16 estudios
De ClinicalTrials.gov, datos obtenidos el 7 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.